Cite
HARVARD Citation
Hou, Y. et al. (n.d.). Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation. Journal for immunotherapy of cancer. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hou, Y. et al. (n.d.). Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation. Journal for immunotherapy of cancer. p. . [Online].